Jeff Himawan - Net Worth and Insider Trading
Jeff Himawan Net Worth
The estimated net worth of Jeff Himawan is at least $0 dollars as of 2024-04-23. Jeff Himawan is the Director of Horizon Therapeutics PLC and owns about 0 shares of Horizon Therapeutics PLC (HZNP) stock worth over $0. Details can be seen in Jeff Himawan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jeff Himawan has not made any transactions after 2015-03-13 and currently still holds the listed stock(s).
Transaction Summary of Jeff Himawan
Jeff Himawan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeff Himawan owns 3 companies in total, including Horizon Therapeutics PLC (HZNP) , Catalyst Biosciences Inc (CBIO) , and MediciNova Inc (MNOV) .
Click here to see the complete history of Jeff Himawan’s form 4 insider trades.
Insider Ownership Summary of Jeff Himawan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HZNP | Horizon Therapeutics PLC | 2015-03-13 | director & 10 percent owner |
| CBIO | Catalyst Biosciences Inc | 2015-08-20 | director |
| MNOV | MediciNova Inc | 2006-01-09 | director |
Jeff Himawan Latest Holdings Summary
Jeff Himawan currently owns a total of 1 stock. Jeff Himawan owns 0 shares of Horizon Therapeutics PLC (HZNP) as of March 13, 2015, with a value of $0.
Latest Holdings of Jeff Himawan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HZNP | Horizon Therapeutics PLC | 2015-03-13 | 0 | 116.30 | 0 |
Holding Weightings of Jeff Himawan
Jeff Himawan Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeff Himawan has made a total of 0 transactions in Horizon Therapeutics PLC (HZNP) over the past 5 years. The most-recent trade in Horizon Therapeutics PLC is the sale of 554,564 shares on March 13, 2015, which brought Jeff Himawan around $12 Million.
Insider Trading History of Jeff Himawan
- 1
Jeff Himawan Trading Performance
GuruFocus tracks the stock performance after each of Jeff Himawan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeff Himawan is 3.28%. GuruFocus also compares Jeff Himawan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeff Himawan within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jeff Himawan's insider trading performs compared to the benchmark.
Performance of Jeff Himawan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.31 | 3.28 | -14.97 | -42.68 | 21.33 | 40.09 |
| Relative Return to S&P 500(%) | 6.7 | 7.27 | -19.17 | -52.51 | 4.67 | 24.59 |
Jeff Himawan Ownership Network
Ownership Network List of Jeff Himawan
Ownership Network Relation of Jeff Himawan
Jeff Himawan Owned Company Details
What does Horizon Therapeutics PLC do?
Who are the key executives at Horizon Therapeutics PLC?
Jeff Himawan is the director & 10 percent owner of Horizon Therapeutics PLC. Other key executives at Horizon Therapeutics PLC include EVP and Chief Business Officer Andy Pasternak , EVP & Chief Financial Officer Aaron Cox , and EVP & Chief Medical Officer Jeffrey W Sherman .
Horizon Therapeutics PLC (HZNP) Insider Trades Summary
Over the past 18 months, Jeff Himawan made no insider transaction in Horizon Therapeutics PLC (HZNP). Other recent insider transactions involving Horizon Therapeutics PLC (HZNP) include a net sale of 40,275 shares made by Jeffrey W Sherman , a net sale of 57,298 shares made by Andy Pasternak , and a net sale of 36,148 shares made by Aaron Cox .
In summary, during the past 3 months, insiders sold 0 shares of Horizon Therapeutics PLC (HZNP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 133,721 shares of Horizon Therapeutics PLC (HZNP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 133,721 shares.
Horizon Therapeutics PLC (HZNP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Horizon Therapeutics PLC Insider Transactions
Jeff Himawan Mailing Address
Above is the net worth, insider trading, and ownership report for Jeff Himawan. You might contact Jeff Himawan via mailing address: Essex Woodlands Health Ventures, 435 Tasso Street, Suite 350, Palo Alto Ca 94301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
